Henrickson Nauta Wealth Advisors, Inc. Gilead Sciences, Inc. Transaction History
Henrickson Nauta Wealth Advisors, Inc.
- $629 Million
- Q4 2025
A detailed history of Henrickson Nauta Wealth Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Henrickson Nauta Wealth Advisors, Inc. holds 14,125 shares of GILD stock, worth $1.75 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
14,125
Previous 7,051
100.33%
Holding current value
$1.75 Million
Previous $782,000
124.04%
% of portfolio
0.28%
Previous 0.25%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
2,386Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...